3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
13
Burkitt Lymphoma
9
Lung Neoplasms
7
Lymphoma, Non-Hodgkin
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Non-Small-Cell Lung
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma
4
Hodgkin Disease
4
Sarcoma, Ewing
3
Recurrence
3
Plasmablastic Lymphoma
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Leukemia
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Immunoblastic Lymphadenopathy
2
HIV Infections
2
Ganglioneuroblastoma
2
Congenital Abnormalities
2
Central Nervous System Neoplasms
2
Interventions
asciminib
8
Cyclophosphamide
8
fludarabine phosphate
6
fludarabine
5
Mycophenolic Acid
5
nilotinib
4
Imatinib Mesylate
4
Whole-Body Irradiation
3
Thiotepa
3
Tacrolimus
3
Granulocyte Colony-Stimulating Factor
3
Dasatinib
3
Cyclosporine
3
venetoclax
2
bosutinib
2
Sirolimus
2
Melphalan
2
Filgrastim
2
Cyclosporins
2
treosulfan
1
thymoglobulin
1
selinexor
1
ruxolitinib
1
ponatinib
1
plerixafor
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
blinatumomab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Etoposide
×
30 days
×
Clear all
No trials found.